Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer

Nature Medicine

Volumn 2, Issue 8, 1996, Pages 912-917

  Sigalas, Iakovos ^a   Calvert, A Hilary ^a   Anderson, John J ^a   Neal, David E ^a   Lunec, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BLADDER CARCINOMA; CANCER GENETICS; CANCER GRADING; CANCER STAGING; CELL STRAIN 3T3; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN TISSUE; LEUKEMIA CELL; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3 CELLS; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; HUMANS; LEUKEMIA; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA; TRANSFORMATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0029824669     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0896-912     Document Type: Article

References (25)

1. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L. & Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83 (1992).
2. Fakharzadeh, S.S., Trusko, S.P. & George, D.L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour cell line. EMBO J. 10, 1565-1569 (1991).
3. Momand, J., Zambetti., G.P., Olson, D.C. & Levine, A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
4. Oliner, J.D. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860 (1993).
5. Leach, F.S. et al. P53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53, 2231-2234 (1993).
6. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E.E. & Collins, V.P. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53, 2736-2739 (1993).
7. Waber, P., Chen, J. & Nisen, P. Infrequency of MDM2 gene amplification in pediatric solid tumours and lack of association with p53 mutations in adult squamous cell carcinomas. Cancer Res. 53, 6028-6030 (1993).
8. Quesnel, B., Preudhomme, C., Fournier, J., Fenaux, P. & Peyrat, J.P. MDM2 gene amplification in human breast cancer. Eur. J. Cancer 30, 982-984 (1994).
9. Barak, Y., Juven, T., Haffne, R. & Oren, M. mam2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468 (1993).
10. Wu, X., Bayle, J.H., Olso, D. & Levine, A.J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132 (1993).
11. Chen, J., Marechal, V. & Levine, A.J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107-1114 (1993).
12. Boddy, M.N., Freemont, P.S. & Borden, K.L.B. The p53-associated protein MDM2 contains a newly characterized zinc-finger domain called the RING finger. Trends Biochem. Sci. 19, 188-189 (1994).
13. Xiao, Z-X. et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375, 694-698 (1995).
14. Martin, K. et al. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375, 691-694 (1995).
15. Olson, D.C. et al. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 8, 2353-2360 (1993).
16. Barak, Y., Gottlieb, E., Juven-Gershon, T. & Oren, M. Regulation of mdm2 expression by p53: Alternative promoters produce transcripts with nonidentical translation potential. Genes Dev. 8, 1739-1749 (1994).
17. Haines, D.S., Landers, J.E., Engle, L.J. & George, D.L. Physical and functional interactions between wild-type p53 and mdm2 proteins. Mol. Cell. Biol. 14, 1171-1178 (1994).
18. Gudas, J.M. et al. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin. Cancer Res. 1, 71-80 (1995).
19. Roberts, B. Nuclear location signal-mediated protein transport. Biochim. Biophys. Acta 1008, 263-280 (1989)
20. 6-methylguanine-DNA methyltransferase. Mutat. Res. DNA Repair Rep. 293, 119-132 (1993).
21. Dubs-Poterszman, M-C., Tocque, B. & Wasylyk, B. MDM2 transformation in the absence of p53 and abrogation of the p107 Gt cell-cycle arrest. Oncogene 11, 2445-2449 (1995).
22. Clifford, S.J., Thomas, D.J., Neal, D.E. & Lunec, J. Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Br. J. Cancer 69, 680-686 (1994).
23. Challen, C., Lunec, J., Warren, W., & Bassendine, M.F. Analysis of the p53 tumour-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 16, 1362-1366 (1992).
24. Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752 (1987).
25. Spandidos, D.A. & Wilkie, N.M. Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310, 469-475 (1984).